Cell And Gene Articles, App Notes, Case Studies, & White Papers

  1. Phase 1 Clinical Trial Designs And Strategies 9/18/2025

    With tailored guidance, sponsors can align their modern model-based and model-assisted design choices to program goals, accelerating progress while safeguarding patients.

  2. Producing MSC-Derived Cell Therapies From Isolation To Large-Scale Expansion 8/4/2025

    Explore the journey of producing MSC-derived cell therapies, from initial isolation and expansion to final product formulation and storage, and learn how to optimize each step.

  3. Enabling CDMOs To Focus On Core Priorities 4/26/2024

    Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.

  4. Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines 3/24/2025

    Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.

  5. Enabling MSC Harvest, Wash, And Concentration 11/17/2025

    A study demonstrates how a low-shear, closed-system centrifuge achieved over 90% MSC recovery and minimized viability loss, supporting scalable cell therapy manufacturing.

  6. Quantitative ROI With DCTs 11/13/2025

    Through dedicated staffing, operational oversight, and collaboration with site teams, see how we were able to transform a struggling cardiology study into a revitalized recruitment effort.

  7. Analysis Of DNA Integrity And Stability Using Digital PCR 5/13/2025

    Digital PCR offers precise, inhibitor-resistant DNA quantification and genome integrity assessment. Discover how this method enhances accuracy and reproducibility, especially in AAV analysis, using multiplexed targets and Poisson-based calculations.

  8. Don't Let Distribution Derail Your CGT Launch 8/7/2025

    Overcoming distribution challenges is critical for the success of cell and gene therapies. Learn how to build a flexible, robust strategy to optimize patient access.

  9. Formulation Development For Therapeutic Oligonucleotides 6/10/2025

    Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.

  10. Modern Lentiviral Platforms For Scalable Cell Therapy 1/20/2026

    A new platform approach streamlines lentiviral vector design and manufacturing, boosting yield, lowering costs, and accelerating access to gene‑modified cell therapies worldwide.